Ordinary Index Rebalancing in the Solactive Pharma Breakthrough Value Index | September 2020

In the ordinary rebalance the following composition will be implemented effective open 21.09.2020:

ALEXION PHARMACEUTICALS INC
BASILEA PHARMACEUTICA LTD.
BEIGENE LTD-ADR
BIOGEN INC
BIOMARIN PHARMACEUTICAL INC
BRISTOL-MYERS SQUIBB CO
CHUGAI PHARMACEUTICAL CO LTD ORD
CSL LTD ORD
EISAI
GENMAB A/S
HALOZYME THERAPEUTICS INC
HORIZON THERAPEUTICS PLC
INCYTE CORP
IONIS PHARMACEUTICALS INC
IPSEN SA
JAZZ PHARMACEUTICALS PLC
KYOWA KIRIN CO LTD
NEKTAR THERAPEUTICS
NIPPON SHINYAKU CO LTD
NOVARTIS AG-ADR
OXFORD BIOMEDICA PLC
ROCHE HOLDING AG
SAREPTA THERAPEUTICS INC
SEATTLE GENETICS INC
SWEDISH ORPHAN BIOVITRUM AB
TORII PHARMACEUTICAL CO LTD
ULTRAGENYX PHARMACEUTICAL INC
UNITED THERAPEUTICS CORP
VERTEX PHARMACEUTICALS INC